Comments on twitter from Sean Sachdev, MD on Lomustine-temozolomide study.
Quote: I recall presented at SNO2017. Some issues: small numbers ~130 pts & imbalance; survival estimate comes from a stratified analysis & they used "inverse probability weights." With the pure unstratified analysis 31.4/37.9 (p=0.66) not statistically significant. Intriguing though.